E-LIB Suche - Ergebnisse für: van der Wekken, A. J

1

Regional differences in predictive biomarker testing rates ..:

de Jager, V.D. ; Cajiao Garcia, B.N. ; Kuijpers, C.C.H.J....
European Journal of Cancer. 205 (2024) - p. 114125 , 2024

Link: https://doi.org/10.1016/..

2

42P Development of an online tool for the management of dru..:

Burger, D. ; Nijboer, L.J. ; van den Heuvel, M....
ESMO Open. 9 (2024) - p. 102621 , 2024

Link: https://doi.org/10.1016/..

3

41P The influence of ROS1 fusion partners and resistance me..:

Zwierenga, F. ; Dijkhuizen, C. ; Korthuis, P....
ESMO Open. 9 (2024) - p. 102620 , 2024

Link: https://doi.org/10.1016/..

4

95P Automatic data processing to identify EGFR mutations in..:

Garcia, B. Cajiao ; Koopman, B. ; de Jager, V....
ESMO Open. 8 (2023) 1 - p. 101905 , 2023

Link: https://doi.org/10.1016/..

5

Safety and tolerability of stereotactic radiotherapy combin..:

Kievit, H. ; Muntinghe-Wagenaar, M.B. ; Hijmering-Kappelle, L.B.M....
Lung Cancer. 178 (2023) - p. 96-102 , 2023

Link: https://doi.org/10.1016/..

6

Trastuzumab-Emtansine and Osimertinib Combination Therapy t..:

Jebbink, M. ; de Langen, A.J. ; Monkhorst, K....
JTO Clinical and Research Reports. 4 (2023) 4 - p. 100481 , 2023

Link: https://doi.org/10.1016/..

7

Safety and efficacy of pralsetinib in RET fusion–positive n..:

Griesinger, F. ; Curigliano, G. ; Thomas, M....
Annals of Oncology. 33 (2022) 11 - p. 1168-1178 , 2022

Link: https://doi.org/10.1016/..

8

EP08.02-109 A Drug-Drug Interaction Study of Mobocertinib a..:

Hanley, M.J. ; Zhang, S. ; Pavlakis, N....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S453-S454 , 2022

Link: https://doi.org/10.1016/..

9

EP08.02-041 NVL-520, a Highly Selective ROS1 Inhibitor, in ..:

Drilon, A. ; Ou, S.-H.I. ; Gadgeel, S....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S416 , 2022

Link: https://doi.org/10.1016/..

10

Safety and preliminary clinical activity of NVL-520, a high..:

Drilon, A. ; Besse, B. ; Camidge, D.R....
European Journal of Cancer. 174 (2022) - p. S6-S7 , 2022

Link: https://doi.org/10.1016/..

11

89Zr-pembrolizumab imaging as a non-invasive approach to as..:

Kok, I.C. ; Hooiveld, J.S. ; van de Donk, P.P....
Annals of Oncology. 33 (2022) 1 - p. 80-88 , 2022

Link: https://doi.org/10.1016/..

12

Trastuzumab and pertuzumab combination therapy for advanced..:

van Berge Henegouwen, J.M. ; Jebbink, M. ; Hoes, L.R....
European Journal of Cancer. 171 (2022) - p. 114-123 , 2022

Link: https://doi.org/10.1016/..

13

Osimertinib treatment for patients with EGFR exon 20 mutati..:

van Veggel, B. ; Madeira R Santos, J.F. Vilacha ; Hashemi, S.M.S....
Lung Cancer. 141 (2020) - p. 9-13 , 2020

Link: https://doi.org/10.1016/..

14

PO-0669: Models of pulmonary function changes after thoraci..:

Niezink, A.G.H. ; Chouvalova, O. ; Ubbels, J.F....
Radiotherapy and Oncology. 123 (2017) - p. S350 , 2017

Link: https://doi.org/10.1016/..

15

Overall survival in EGFR mutated non-small-cell lung cancer..:

van der Wekken, A. J. ; Kuiper, J. L. ; Saber, A....
PLOS ONE. 12 (2017) 8 - p. e0182885 , 2017

Link: https://doi.org/10.1371/..